$8.24
6.32%
Nasdaq, Jun 28, 10:00 pm CET
ISIN
US53630X1046
Symbol
LPCN
Sector
Industry

Lipocine, Inc. Target price 2024 - Analyst rating & recommendation

Lipocine, Inc. Classifications & Recommendation:

Buy
100%

Lipocine, Inc. Target price

Target price $33.00
Course $8.24
Price potential
Number of estimates 1
1 Analyst has issued a Lipocine, Inc. price target 2025. The average Lipocine, Inc. target price is $33.00. This is higher than the current share price.
A rating was issued by 1 analysts: 1 Analysts recommend Lipocine, Inc. to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst estimates: Analysts believe that the Lipocine, Inc. share has an average upside potential 2025 of . Most analysts recommend the Lipocine, Inc. share at Purchase.

Sales and margin forecast 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Forecast
Turnover Million $ 0.11 8.95
78.00% 8,037.27%
Net margin -15,186.18% -59.43%
589.50% 99.61%

1 Analyst has issued a sales forecast Lipocine, Inc. 2024 . The average Lipocine, Inc. sales estimate is

$9.0m
unlock
. This is
16.70% higher
unlock
than the turnover of the last 12 months(TTM). The highest sales forecast is
$9.0m 16.70%
unlock
, the lowest is
$9.0m 16.70%
unlock
.

This results in the following potential growth figures:

Sales forecast

2023 $110k 78.00%
2024
$9.0m 8,037.27%
unlock
2025
$16.3m 81.58%
unlock

1 Analyst has issued a net profit forecast Lipocine, Inc. 2024 . The average Lipocine, Inc. net profit estimate is

$-5.3m
unlock
. This is
41.86% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-5.3m 41.86%
unlock
, the lowest is
$-5.3m 41.86%
unlock
.

This results in the following potential growth figures and future net margins:

Net profit forecast

2023 $-16.7m 51.69%
2024
$-5.3m 68.15%
unlock
2025
$-320k 93.98%
unlock

Net margin

2023 -15,186.18% 589.50%
2024
-59.43% 99.61%
unlock
2025
-1.96% 96.70%
unlock

Earnings per share, P/E ratio and EV/sales forecast 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Forecast
Earnings per share $ -3.14 -1.00
51.69% 68.15%
P/E ratio negative
EV/Sales 2.17

1 Analysts have issued a Lipocine, Inc. forecast for earnings per share. The average Lipocine, Inc. <a href=/blog/eps>EPS is

$-1.00
unlock
. This is
41.86% higher
unlock
than earnings per share in the financial year 2023. The highest <a href=/blog/eps>EPS forecast is
$-1.00 41.86%
unlock
, the lowest is
$-1.00 41.86%
unlock
.

This results in the following potential growth figures and future valuations:

Earnings per share

2023 $-3.14 51.69%
2024
$-1.00 68.15%
unlock
2025
$-0.06 94.00%
unlock

P/E ratio

Current -4.78 102.54%
2024
-8.24 72.38%
unlock
2025
-137.33 1,566.63%
unlock

Based on analysts' sales estimates for 2024, the Lipocine, Inc. share is valued at an <a href=/blog/ev-sales-einfach-erklaert>EV/Sales of

and an <a href=/blog/kurs-umsatz-verhaeltnis-kuv-einfach-erklaert>P/S ratio of .

This results in the following potential growth figures and future valuations:

EV/Sales

Current 2.53 138.98%
2024
2.17 14.16%
unlock
2025
1.20 44.93%
unlock

P/S ratio

Current 5.75 87.51%
2024
4.92 14.31%
unlock
2025
2.71 44.93%
unlock

Register for free

StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.

The Apple share at a glance with charts, current key figures, news and share analyses.
The best dividend stocks in the dividend top scorer list.
Stock analyses of the best stocks worldwide.
Build wealth now